Psychiatric morbidity in psoriasis: a review

The Australasian Journal of Dermatology
Paul A J RussoAlan J Cooper

Abstract

Psoriasis is a common condition, affecting 1.5-2% of the population of industrialized countries. It is important for clinicians to be aware that psoriasis can have a substantial emotional impact on an individual, which is not necessarily related to the extent of skin disease. This review examines current literature addressing the psychological and emotional aspects of psoriasis. A literature search of the MEDLINE (1966-2002) and PsycINFO (1984-2002) computer databases and bibliographies was carried out. Papers selected for the review included English language reviews and all original research relevant to the topic, in the form of randomized controlled trials, cohort studies, case-control studies, cross-over and uncontrolled clinical trials, patient surveys, quality-of-life studies, case series and case reports. Despite significant shortcomings, the available prevalence studies showed uniformly high rates of psychopathology among psoriasis sufferers. The few intervention studies available are summarized and critically discussed. Psoriasis is associated with a variety of psychological problems, including poor self esteem, sexual dysfunction, anxiety, depression and suicidal ideation. The clinical severity of the psoriasis may not...Continue Reading

References

Feb 1, 1992·The Annals of Pharmacotherapy·C HemlockA Winston
Jan 1, 1989·Journal of the American Academy of Dermatology·I H Ginsburg, B G Link
Jan 1, 1985·Social Science & Medicine·S Jowett, T Ryan
Apr 1, 1995·Journal of the American Academy of Dermatology·C S Koblenzer
Feb 1, 1994·The British Journal of Dermatology·M S Al'AbadieD J Gawkrodger
Mar 1, 1993·International Journal of Dermatology·M A GuptaC N Ellis
May 1, 1993·Journal of the American Academy of Dermatology·M A GuptaC N Ellis
Jun 1, 1996·Journal of the American Academy of Dermatology·R ZachariaeK Kragballe
Jun 1, 1996·Journal of the American Academy of Dermatology·M A Gupta, A K Gupta
Jan 1, 1997·General Hospital Psychiatry·P W WoodruffS Wessely
Apr 1, 1997·International Journal of Dermatology·M A Gupta, A K Gupta
Aug 15, 1998·Journal of the American Academy of Dermatology·D G FortuneC E Griffiths
Aug 25, 1999·Journal of the American Academy of Dermatology·S R RappD M Reboussin
Mar 10, 2000·Journal of Affective Disorders·H H ChanS Lee
Feb 24, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·H Devrimci-OzguvenA Boyvat
May 8, 2001·Psychotherapy and Psychosomatics·A Picardi, D Abeni
Jun 26, 2001·Journal of the American Academy of Dermatology·B KirbyC E Griffiths
Nov 13, 2001·The British Journal of Dermatology·S R RappM R Leary
Apr 16, 2002·The British Journal of Dermatology·D G FortuneC E M Griffiths
Jun 20, 2002·The British Journal of Dermatology·R ZachariaeB Sigurgeirsson
Jun 20, 2002·The British Journal of Dermatology·N H CoxH Dodd
Aug 3, 2002·The American Journal of Psychiatry·Mark OlfsonMilton Fuentes
Sep 25, 2002·Psychosomatic Medicine·Jack G ModellCharles Katholi

❮ Previous
Next ❯

Citations

Apr 8, 2011·Journal of General Internal Medicine·Rita V PatelRobert S Kirsner
Dec 10, 2013·Dermatology and Therapy·Hee-Sun MoonSandy R McBride
Nov 17, 2010·Pediatric Dermatology·Ayhan BilgicEmine Zinnur Kılıç
Oct 22, 2013·BMC Family Practice·Pauline A NelsonUNKNOWN IMPACT Team
Aug 10, 2010·Core Evidence·Eliana Krulig, Kenneth B Gordon
Dec 25, 2010·Indian Journal of Psychiatry·K H BasavarajR Rashmi
May 17, 2014·Applied Research in Quality of Life·Beata Szramka-PawlakRyszard Zaba
Aug 29, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Jason Jingjie YuChuanjian Lu
Dec 3, 2014·The Psychiatric Clinics of North America·Edgardo Rodriguez-Vallecillo, Michel A Woodbury-Fariña
May 7, 2015·International Journal of Dermatology·Ilknur BaltaHatice Burakgazi-Yilmaz
Sep 16, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·B PolistenaF Ayala
Jan 17, 2012·Journal of the American Academy of Dermatology·Alexa B KimballParvez M Mulani
Jan 31, 2012·Dermatologic Clinics·Misha M HellerJohn Y M Koo
Mar 2, 2010·Sleep Medicine Reviews·Patrick T Thorburn, Renata L Riha
Jun 17, 2006·The Journal of Investigative Dermatology·Ray Jobling, Luigi Naldi
Mar 3, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·A T Ermertcan
Jan 24, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·I D BassukasV Mavreas
Apr 29, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·O AricanO Ozbulut
Nov 1, 2006·The Journal of Dermatology·Aylin Türel ErmertcanSerap Oztürkcan
Jul 16, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·P J MaginS M Goode
Sep 27, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·A FinziUNKNOWN PSYCHAE Study Group
Jul 17, 2010·The British Journal of Dermatology·K AbuabaraJ M Gelfand
Jun 28, 2011·International Journal of Dermatology·Kabbur H BasavarajRamesh Rashmi
Nov 9, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·E DaudénUNKNOWN Working Group on Comorbidity in Psoriasis
Oct 5, 2010·The Journal of Dermatology·Edita SimonićIgor Kardum
Feb 15, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·D BöhmG Schmid-Ott
Feb 27, 2016·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Claire Shuiqing ZhangCharlie Changli Xue
Apr 21, 2016·Journal of Psychosomatic Research·Uwe Matterne, Christian Apfelbacher
Aug 14, 2012·The British Journal of Dermatology·P A NelsonUNKNOWN IMPACT Team
Apr 4, 2012·Actas dermo-sifiliográficas·E DaudénUNKNOWN Grupo de Trabajo en Comorbilidades asociadas a la Psoriasis
May 6, 2008·The American Journal of Medicine·Michael L ShellingRobert S Kirsner
Mar 31, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·S I TeeY C Giam
Jan 13, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Tal FriedmanYoram Barak
Apr 16, 2013·Redox Report : Communications in Free Radical Research·Fatih KarababaSahabettin Selek
Jun 15, 2015·Paediatric Drugs·I M G J BronckersM M B Seyger
Oct 7, 2010·The Journal of Dermatological Treatment·Ji Ying TanJunying Zhang
Jul 9, 2011·Expert Opinion on Pharmacotherapy·Jonathan P StaidleSteven R Feldman
Jun 21, 2012·Expert Opinion on Pharmacotherapy·Brandon ShuttySteven Feldman
Mar 16, 2013·International Journal of Cardiology·Maddalena GaetaRiccardo Cappato
Oct 25, 2011·Neuroscience and Biobehavioral Reviews·Michael J Stuart, Bernhard T Baune

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Dermatology : International Journal for Clinical and Investigative Dermatology
Maria EspositoS Chimenti
American Journal of Clinical Dermatology
A B KimballY Wu
JAMA : the Journal of the American Medical Association
Joel M GelfandAndrea B Troxel
© 2022 Meta ULC. All rights reserved